Antinuclear antibodies: Is the indirect immunofluorescence still the gold standard or should be replaced by solid phase assays?

Dolores Pérez Boris Gilburd Danielle Azoulay Ora Shovman Nicola Bizzaro Yehuda Shoenfeld

Autoimmun Rev

Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel; Laboratory of the Mosaic of Autoimmunity, Department of Pathology, Faculty of Medicine, Saint Petersburg State University, Russia; Sackler Faculty of Medicine, Tel-Aviv University, Israel; Incumbent of the Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Sackler Faculty of Medicine, Tel-Aviv University, Israel. Electronic address:

Published: June 2018

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.autrev.2017.12.008	DOI Listing

Publication Analysis

Top Keywords

antinuclear antibodies

antibodies indirect

indirect immunofluorescence

immunofluorescence gold

gold standard

standard replaced

replaced solid

solid phase

phase assays?

antinuclear

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!